NIH-funded research R21 grant

Understanding how oxytocin affects contractions in engineered human uterine tissue

Official title: Quantitating Oxytocin-induced Contractility in Bioengineered 3D Human Myometrium

Funded at Texas Engineering Experiment Station · NIH-11117725 · Data updated 2026-11-12

This study is looking at how different amounts of oxytocin affect the contractions of a special model of human uterine muscle, which could help doctors use this hormone more safely during labor for expecting moms.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$235,803
NIH project number1R21HD118295-01
Project IDNIH-11117725 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant women who are approaching term (over 37 weeks of gestation) and may require oxytocin for labor induction or augmentation.

Less likely to help

Patients who are not pregnant or those who are not at term may not benefit from this research.

What this research studies

This research investigates the effects of oxytocin on the contractility of bioengineered human myometrium, which is the muscle layer of the uterus. By creating a 3D model of human uterine tissue using cells from patients, the researchers aim to better understand how different doses of oxytocin influence muscle contractions during labor. This could lead to improved dosing strategies for oxytocin, potentially reducing the risks associated with its use during childbirth. The study will utilize advanced bioengineering techniques to create a more accurate representation of human uterine tissue for testing.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective use of oxytocin during labor, improving outcomes for mothers and newborns.

How similar studies have gone: While the approach of using bioengineered tissues is innovative, similar studies have shown promise in understanding uterine contractility, suggesting potential for success.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Raghavan, Shreya — Texas Engineering Experiment Station
  • Study coordinator: Raghavan, Shreya

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.